Microfluidic Market to Actively Foray into Emerging Consumer Marketplaces During 20182026 Microfluidic devices enables the precise processing of micro liter (~0.01-10 µl) samples and allows to perform significant biological or chemical processing such as sampling, pre-processing and measurement involved in an assay within a single chip. Microfluidics aids in handling and examining very small fluid volumes, around micro- (10 -6) to atto- (10-18) liter volumes of fluid, which provides several analytical and economic advantages over the conventional assays. Microfluidic devices typically requires 10x times less sample volume, thereby allowing less sample and reagent consumption. Microfluidic devices transfers such small amount of fluid volume through microfluidic channels, which provides higher surface area to volume ratio, which further enhance the heat transfer. Increasing advancements in microfluidics such as labon-a-chip device for DNA amplification, purification, separation and sequencing, and single cell gene-expression profiling is expected to aid in growth of the market. Microfluidic provides enhanced analytical sensitivity, enhanced temperature control, faster reaction time, cost efficiency and allows integration of lab routines in a single device. Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1086 The global microfluidic market was valued at US$ 2.8 billion in 2016 and is expected to witness a robust CAGR of 19.4% over the forecast period (2017–2025). Market Dynamics: Major factors influencing growth of the microfluidic market is rising demand for point-of-care (POC) testing and advancements in microfluidic technology to reduce cost of sample analysis and enabling higher efficiency. Moreover, increasing demand for home healthcare to address growing prevalence of diabetes is supporting to growth of the microfluidic market. For instance, in 2017 researchers at the Ewha Womens University developed an endocrine system on chip, based on microfluidic perfused 3D cell-culture chip which detect the drugs for the treatment of diabetes by measuring insulin release over time. According to the statistics published by International Diabetes Federation (IDF), the global prevalence of diabetes is around 424.9 million in 2017, which is expected to increase to 628.6 million in 2045. In addition, increasing innovation in microfluidics technology is further expected to bolster growth of the market. Researchers at the Brigham Young University, in April 2017, developed first 3D-print viable microfluidic device which has size less than 100 micrometers and employed to use in molecular biology, proteomics and cell biology diagnostic technologies. Report includes chapters which deeply display the following deliverable about industry : • Microfluidic Market Research Objective and Assumption • Microfluidic Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Microfluidic Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Microfluidic Market, By Regions • Microfluidic Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Microfluidic Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Microfluidic Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Microfluidic Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Rising demand for point-of-care testing to augment microfluidic market growth: Point-of-care testing (POC Testing) is medical diagnostic testing performed primarily outside medical care facilities and in close proximity that is at the time and place of patient care. Point-of-care testing is relatively expensive than regular lab testing; however, it offers appropriate and immediate results for further clinical management. Microfluidic technology primarily offers three advantages to POC diagnostic: smaller sample volume, lower test costs, and faster detection time. Point-of-care testing enables miniaturization and integration of complex functions facilitating their usage in limited resources. Continuous innovation strategy adopted by manufacturers is expected to aid in accelerating growth of the microfluidic market: Adoption of microfluidics as a key technology in medical science and biosensing is increasing significantly in the recent past. Manufacturers are focusing on continuous innovation in microfluidic technology such as laboratory-on-a-chip, point-of-care testing, microfluidic enabled drug delivery systems, and microfluidic gradient generators to enhance their product portfolios. Introduction of thermoplastic as a new material for microfluidic device fabrication instead of conventional PDMS polymer, adoption of novel microfluidic flow rate detection method, and advancement in nanoparticle separation using microfluidic devices is further expected to boost the microfluidic market in the near future. Microfluidic techniques are being extensively used to separate micro sized particles such as blood cells, parasites, spores, tumor cells, and bacteria due to its advantages such as low sample volume, low cost, and miniature sample handing with precise control. However, to separate submicron particle, nanofluidics is emerging as a suitable technology for separation. Some of the major players operating in the microfluidic market are Abbott Laboratories, Agilent Technologies, Thermo Fisher Scientific Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Fluidigm Corporation, Danaher Corporation, PerkinElmer Inc., Siemens Healthcare GmbH, and Micronit Microfluidic BV Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1086 Detailed Segmentation: • Global Microfluidic Market, By Material Type: • Silicon-Based Microfluidic • Glass-Based Microfluidic • Polymer-Based Microfluidic • Other Materials- Based (Paper & Ceramics) Microfluidic • Global Microfluidic Market, By Application: • In Vitro Diagnostic Devices • Drug Delivery Devices • Monitoring Devices • Global Microfluidic Market, By Geography: • North America • Europe • Asia Pacific • Latin America • Middle East • Africa About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected]
Microfluidic devices enables the precise processing of micro liter (~0.01-10 µl) samples and allows to perform significant biological or chemical processing such as sampling, pre-processing and measurement involved in an assay within a single chip.
© Copyright 2024 Paperzz
